What is the best time for psychosocial counselling from the perspective of cancer patients and their relatives? A multi-centre qualitative study

被引:6
|
作者
Singer, Susanne [1 ,2 ]
Kojima, Erika [1 ,2 ]
Deppisch, Larissa [1 ,2 ]
Taylor, Katherine [1 ,2 ]
Wickert, Martin [3 ]
Riedel, Petra [3 ]
Alt, Juergen [2 ]
Hess, Georg [2 ]
Hechtner, Marlene [1 ,2 ]
Bayer, Oliver [1 ,2 ]
机构
[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Med Biostat Epidemiol & Informat IMBEI, Div Epidemiol & Hlth Serv Res, Obere Zahlbacher Str 69, D-55131 Mainz, Germany
[2] Univ Canc Ctr Mainz UCT, Mainz, Germany
[3] Canc Counselling Ctr, Tubingen, Germany
关键词
counselling; gender; help-seeking; optimal time-point; preferences; timing; DECISION-MAKING; BREAST-CANCER; CARE; DEPRESSION; SERVICES; SUPPORT; DISTRESS; IMPACT; INTERVENTIONS; ANXIETY;
D O I
10.1002/capr.12488
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Purpose The aim of this study was to identify at what time patients with cancer and their relatives want to be informed about and receive psychosocial counselling. Methods In a multi-centre prospective study, both users and non-users of psychosocial cancer counselling were asked to participate in a qualitative interview about their preferences for psychosocial counselling. A second interview was scheduled 3-6 months thereafter. Interviews were transcribed verbatim and coded according to content analysis. Results Altogether, 61 patients and 42 relatives participated, resulting in 183 interviews (103 at t1, 80 at t2). Most often, the optimal time-point for cancer counselling was defined by the participants according to the treatment trajectory, and the most frequently mentioned preferred time-point was 'as early as possible': at the time of cancer diagnosis (mentioned in 22% of interviews with men and 10% of interviews with women). In particular, men also said that they wanted psychosocial counselling while waiting for test results (5%), at the point of returning to work and/or when under the threat of unemployment (3%). Women especially preferred this support during therapy (4%) and 'when one has the capacity for it' (4%), in terms of time and emotional capacity. Conclusions Healthcare providers should inform their cancer patients and the relatives about the possibilities of professional psychosocial support early on in the disease trajectory (i.e. at the time of diagnosis) and repeatedly thereafter, especially in times of uncertainty, while ensuring the patients' capacity to process information at each time-point is taken into consideration.
引用
收藏
页码:558 / 568
页数:11
相关论文
共 50 条
  • [41] Structured multi-disciplinary psychosocial care for cancer patients and the perceived quality of care from the patient perspective: a cluster-randomized trial
    Susanne Singer
    Helge Danker
    Jürgen Meixensberger
    Susanne Briest
    Andreas Dietz
    Rolf-Dieter Kortmann
    Jens-Uwe Stolzenburg
    Anette Kersting
    Julia Roick
    Journal of Cancer Research and Clinical Oncology, 2019, 145 : 2845 - 2854
  • [42] Nurse-patient communication experiences from the perspective of Iranian cancer patients in an outpatient oncology clinic: a qualitative study
    Azarabadi, Afsaneh
    Bagheriyeh, Farzaneh
    Moradi, Yaser
    Orujlu, Samira
    BMC NURSING, 2024, 23 (01):
  • [43] Towards person-centred care for people living with HIV: what core outcomes matter, and how might we assess them? A cross-national multi-centre qualitative study with key stakeholders
    Bristowe, K.
    Clift, P.
    James, R.
    Josh, J.
    Platt, M.
    Whetham, J.
    Nixon, E.
    Post, F. A.
    McQuillan, K.
    Ni Cheallaigh, C.
    Murtagh, F. E. M.
    Anderson, J.
    Sullivan, A. K.
    Harding, R.
    HIV MEDICINE, 2019, 20 (08) : 542 - 554
  • [44] The challenge of managing mild to moderate distress in patients with end stage renal disease: results from a multi-centre, mixed methods research study and the implications for renal service organisation
    Sarah Damery
    Kim Sein
    Johann Nicholas
    Jyoti Baharani
    Gill Combes
    BMC Health Services Research, 19
  • [45] Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC - PathoBiology Group
    Span, P. N.
    Sieuwerts, A. M.
    Heuvel, J. J. T. M.
    Spyratos, F.
    Duffy, M. J.
    Eppenberger-Castori, S.
    Vacher, S.
    O'Brien, K.
    McKiernan, E.
    Pierce, A.
    Vuaroqueaux, V.
    Foekens, J. A.
    Sweep, F. C. G. J.
    Martens, J. W. M.
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (01) : 74 - 81
  • [46] What Patients Facing Cancer and Caregivers Want From Communication in Times of Crisis: A Qualitative Study in the Early Months of the COVID-19 Pandemic
    Singh, Nainwant
    Giannitrapani, Karleen F.
    Gamboa, Raziel C.
    O'Hanlon, Claire E.
    Fereydooni, Soraya
    Holdsworth, Laura M.
    Lindvall, Charlotta
    Walling, Anne M.
    Lorenz, Karl A.
    AMERICAN JOURNAL OF HOSPICE & PALLIATIVE MEDICINE, 2024, 41 (05) : 558 - 567
  • [47] What do patients with a rare cancer living in rural, regional or remote areas and stakeholders want from a peer support program? A qualitative study
    Hemming, L.
    Duijts, S. F. A.
    Cockburn, C.
    Wilson, C.
    Yuen, E. Y. N.
    Spelten, E.
    BMC CANCER, 2025, 25 (01)
  • [48] Resilience and vulnerability of post-ostomy patients with early-onset colorectal cancer from the perspective of social-ecological theory: a qualitative study
    Yang, Fangfang
    Feng, Fangming
    Gu, Hongming
    Liang, Han
    Zhang, Jin
    Cheng, Yusha
    Zhang, Weiying
    FRONTIERS IN PSYCHIATRY, 2025, 15
  • [49] Renal staffs' understanding of patients' experiences of transition from peritoneal dialysis to in-centre haemodialysis and their views on service improvement: A multi-site qualitative study in England and Australia
    Jones, Janet E.
    Damery, Sarah L.
    Allen, Kerry
    Johnson, David W.
    Lambie, Mark
    Holvoet, Els
    Davies, Simon J.
    PLOS ONE, 2021, 16 (07):
  • [50] Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity A subgroup analysis of a large multi-centre, prospective, internet-based study
    Blumenstein, I.
    Herrmann, E.
    Filmann, N.
    Zosel, C.
    Tacke, W.
    Bock, H.
    Dignass, A.
    Hartmann, F.
    Zeuzem, S.
    Stein, J.
    Schroeder, O.
    JOURNAL OF CROHNS & COLITIS, 2011, 5 (03) : 203 - 210